title: Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.
authors.affiliation: Department of Medicine.
authors.forename: G G
authors.initials: GG
authors.lastname: Malouf
authors.affiliation: Department of Pathology.
authors.forename: J
authors.initials: J
authors.lastname: Duclos
authors.affiliation: Department of Biostatistics.
authors.forename: A
authors.initials: A
authors.lastname: Rey
authors.affiliation: Department of Pathology.
authors.forename: P
authors.initials: P
authors.lastname: Duvillard
authors.affiliation: Department of Platform of Genomics.
authors.forename: V
authors.initials: V
authors.lastname: Lazar
authors.affiliation: Department of Radiotherapy.
authors.forename: C
authors.initials: C
authors.lastname: Haie-Meder
authors.affiliation: Department of Radiology.
authors.forename: C
authors.initials: C
authors.lastname: Balleyguier
authors.affiliation: Department of Surgery, Institut Gustave-Roussy, Villejuif, France.
authors.forename: P
authors.initials: P
authors.lastname: Morice
authors.affiliation: Department of Medicine.
authors.forename: C
authors.initials: C
authors.lastname: Lhommé
authors.affiliation: Department of Medicine. Electronic address: pautier@igr.fr.
authors.forename: P
authors.initials: P
authors.lastname: Pautier
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001918:Brachytherapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D016889:Endometrial Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D010386:Pelvic Neoplasms / Q000556:secondary / Q000628:therapy*; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D018203:Sarcoma, Endometrial Stromal / Q000473:pathology / Q000628:therapy*; D015996:Survival Rate